Full-Time

Electrophysiologist

Confirmed live in the last 24 hours

Zoetis

Zoetis

5,001-10,000 employees

Food & Agriculture
Healthcare

Senior

Kalamazoo, MI, USA

Category
Lab & Research
Life Sciences
Medical Research

You match the following Zoetis's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • BA/BS, MS, or Ph.D. in Electrophysiology, Biochemistry, Neurobiology, and Molecular biology techniques or related science
  • BS degree with a minimum of 5-8 years' experience, MS degree with a minimum of 3-6 years' experience or Ph.D. with a minimum of 2 years’ experience
  • Hands-on experience with the patch clamp technique (manual required and automated optional)
  • Understanding of ion channel physiology, cell signaling associated with channel function and dysfunction
  • Hands-on experience with at least one of the following: 2D cell culture (overexpression cell systems such as HEK, CHO, etc), primary cells, and iPS cells
  • Must have some hands-on experience with drug screening or toxicological assessments, with willingness to work with toxic compounds of interest
  • Must be able to design, plan, and execute experiments to understand electrophysiological effects of compounds of interest
  • Good oral, written, and interpersonal communication skills are required
  • Basic computer skills such as data entry
  • Ability to organize time independently and prioritize workload to meet objectives in a flexible, team-oriented environment
Responsibilities
  • Conduct electrophysiology assessments on overexpression cell lines
  • Measure calcium handling on multiple platforms on iPS cells or overexpression cell lines
  • Perform screening of compounds of interest and their effect on ion channel activity, whether that be in cell lines, iPS cells or primary cells
  • Keep detailed records of laboratory experiments and compile data in regular technical reports
  • Interprets and presents data to project teams
Desired Qualifications
  • High productivity
  • Ability to multi-task
  • Problem solving
  • Attention to detail
  • Willingness and ability to learn
  • Ability to work in a team environment

Company Size

5,001-10,000

Company Stage

IPO

Total Funding

$14.9M

Headquarters

Parsippany-Troy Hills, New Jersey

Founded

1952

Simplify Jobs

Simplify's Take

What believers are saying

  • Zoetis benefits from the growing veterinary telehealth market and increased pet ownership.
  • The rise of pet insurance boosts demand for Zoetis' advanced veterinary services.
  • Zoetis' focus on sustainable practices aligns with industry trends and consumer preferences.

What critics are saying

  • Emerging biotech firms in animal health could threaten Zoetis' market share.
  • Alternative protein sources may reduce demand for traditional animal health products.
  • Animal rights backlash against testing practices could harm Zoetis' public image.

What makes Zoetis unique

  • Zoetis leads the animal health industry with innovative products like Vetscan OptiCell.
  • The company has a strong history, originating from a Pfizer spinoff in 2013.
  • Zoetis collaborates with institutions like Colorado State University for sustainable animal production.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Hybrid Work Options

Company News

MarketBeat
Jan 17th, 2025
Miracle Mile Advisors LLC Makes New $272,000 Investment in Zoetis Inc. (NYSE:ZTS)

Miracle Mile Advisors LLC makes new $272,000 investment in Zoetis Inc. (NYSE:ZTS).

TipRanks
Jan 13th, 2025
Zoetis Highlights Growth at J.P. Morgan Conference

Zoetis announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference, showcasing its exemplary 2024 performance and strategic growth initiatives.

Stock Titan
Jan 7th, 2025
Is Zoetis Inc. (NYSE: ZTS) Overvalued? Or Is It Worth Buying Now?

BetterInvesting Magazine has selected Zoetis (NYSE: ZTS) as its 'Stock to Study' for the March 2025 issue, suggesting the stock warrants further investigation by investors.

Grand View Research
Jan 1st, 2025
Animal Health Market Size To Reach $112.33 Billion By 2030

For instance, in January 2021, Zoetis launched the Poulvac Procerta HVT-IBD vaccine for poultry to protect against Infectious Bursal Disease (IBD).

Governance Intelligence
Dec 31st, 2024
GeneDx appoints former Zoetis general counsel as legal chief

Chen has joined GeneDx from Zoetis, where she was general counsel and corporate secretary for almost 12 years, a role she took on following the company's spinoff from Pfizer in 2013.